Showing results (31-40 of 432) with videos related to
Sort By:
Pageof 44
Cancer Research|July 19, 2002
Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinomaMichael Bonham, Hugh Arnold, Bruce Montgomery, et al.Bioinformatics (Oxford, England)|April 6, 2010
Supervised normalization of microarraysBrigham H Mecham, Peter S Nelson, John D StoreyUrology|May 27, 2008
Prostate tissue androgens: history and current clinical relevanceLeonard S Marks, Elahe A Mostaghel, Peter S NelsonExpert Review of Molecular Diagnostics|July 16, 2010
Genomic predictors of prostate cancer therapy outcomesDaniel J Lewinshtein, Christopher R Porter, Peter S NelsonMolecular and Cellular Endocrinology|March 29, 2012
Androgen action and metabolism in prostate cancerSean M Green, Elahe A Mostaghel, Peter S NelsonNucleic Acids Research|December 26, 2001
The human (PEDB) and mouse (mPEDB) Prostate Expression DatabasesPeter S Nelson, Colin Pritchard, Denise Abbott, et al.BJU International|September 3, 2011
Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminomaDan Lewinshtein, Roman Gulati, Peter S Nelson, et al.Bioinformatics (Oxford, England)|June 8, 2004
Bayesian integrated functional analysis of microarray dataMadhuchhanda Bhattacharjee, Colin C Pritchard, Peter S Nelson, et al.Nature Clinical Practice. Urology|February 10, 2009
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletionWilliam P Harris, Elahe A Mostaghel, Peter S Nelson, et al.Gene|July 26, 2002
Isolation and characterization of the murine prostate short-chain dehydrogenase/reductase 1 (Psdr1) gene, a new member of the short-chain steroid dehydrogenase/reductase familyStacy Moore, Colin Pritchard, Biaoyang Lin, et al.Pageof 44